Business Wire

Scotland’s Patient Safety Programme Makes a Commitment to the Patient Safety Movement Foundation

20.5.2016 07:03 | Business Wire

Del

The Patient Safety Movement Foundation (PSMF) announced today a commitment from Scotland’s national patient safety initiative, the Scottish Patient Safety Programme (SPSP).

Launched in 2008, the SPSP first started as a five-year program focused on acute hospitals and now operates as a national initiative managed by Healthcare Improvement Scotland aimed at improving the safety and reliability of healthcare, whenever care is delivered.

SPSP’s commitment through the Patient Safety Movement Foundation is broken down into the 6 different areas listed below. Central to all of the areas are three core themes: 1) Prevention, recognition and response to deterioration 2) Medicines Safety and 3) System enablers. For complete details, please visit their commitment online.

  • Acute Adult: Improving reliable care delivery, communication and care planning & reducing harm and mortality in hospitals
  • Hospital Acquired Infections (HAIs): Application of standard infection control precautions (SICPs) in all care settings & achieving reliable systems and processes around the reduction of HAIs
  • Primary Care: Improving safety across the community and across the interface & reducing harm from high risk medicines
  • Maternity and Children (includes pediatric and neonatal care): Improving outcomes for babies, children and their mothers & increasing women’s satisfaction of their experience of care
  • Medication: Taking a whole system approach to the safer use of medicines
    & optimizing medication reconciliation and reducing harm from high risk medicines
  • Mental Health: Improving risk assessment and safety planning & reducing harm from restraint and seclusion

The programme’s goals include:

  • Improving patient safety in acute care by ensuring 95% of people are free from harm in the following areas: Cardiac Arrest, Catheter-associated Urinary Tract Infection (CAUTI), pressure ulcers and falls
  • Reducing the hospital-standardized mortality ratio (HSMR) by 20%
  • Increasing the percentage of women satisfied with their experience of maternity care to >95%
  • Reducing the incidence of avoidable harm in women and babies by 30%
  • Reducing stillbirths and neonatal mortality by 15%
  • Reducing severe post-partum haemorrhage (PPH) by 30%
  • Reducing the incidence of non-medically indicated elective deliveries prior to 39 weeks gestation by 30%
  • General Dental Practice Teams plan to achieve 90% compliance with high risk medications care bundle by December 2016
  • 50% of Primary Care Clinical Teams plan to complete a Safety Climate Survey and develop their safety culture by March 2017
  • Reducing pressure ulcers in care homes by 50% by December 2017
  • Ensuring that within Mental Health inpatient units, both the patients and staff are kept safe and feel safe

“We are excited to be working with the Patient Safety Movement Foundation,” said Joanne Matthews, Head of the SPSP. “Our programme has to date been delivered through a collaborative approach based on the Breakthrough Series Collaborative Model, using national and local learning events, site visits , webinars, collecting data and sharing learning across the country. With ongoing programme expansion and development, a range of other improvement methods are now being tested.”

“We are impressed with Scotland’s Patient Safety program and their government’s focus on making patient safety a top priority,” said Joe Kiani, Founder of the Patient Safety Movement Foundation “Patient safety is a global issue and we hope to assist in breaking down the silos in the healthcare eco-system around the world. We can help each other move towards attaining zero faster.”

About The Patient Safety Movement Foundation

More than 3,000,000 people worldwide, and 200,000 people in the US die every year in hospitals in ways that could have been prevented. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare, to reduce that number of preventable deaths to 0 by 2020 (0X2020) in the US and dramatically worldwide. Improving patient safety will require a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The Patient Safety Movement Foundation works with all stakeholders to address the problems and solutions of patient safety. The Foundation also convenes the annual World Patient Safety, Science and Technology summit. The Summit presents specific, actionable solutions to meet patient safety challenges, encouraging medical technology companies to share the data for which their products are purchased, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions. Visit www.patientsafetymovement.org.

@0x2020 #patientsafety #0x2020

Contact information

The Patient Safety Movement Foundation
Irene Paigah, 858-859-7001
irene@paigah.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08Pressemelding

Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven

Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00Pressemelding

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and

Permasteelisa Group to Join Grandland21.8.2017 04:11Pressemelding

Worldwide leading contractor in engineering, project management, manufacturing and installation of architectural envelopes and interior systems, Permasteelisa Group, will join forces with Grandland Group – a fast growing, Shenzhen-based specialist in design and construction of architectural decoration. The strategic alliance will create the biggest, most comprehensive curtain wall player in the world, with exceptional potential for further growth for both companies. Permasteelisa will remain fully committed to build avant-garde architectures and top end, high-quality projects which have become its trademark. The news comes today after LIXIL Group Corporation (LIXIL Group) (TOKYO: 5938) – a global leader in the housing and building industry – announced that it has decided to sell 100% of shares of Permasteelisa S.p.A., held by its major subsidiary LIXIL Corporation, to Grandland Holding

LIXIL to Sell Permasteelisa to Grandland21.8.2017 03:42Pressemelding

LIXIL Group Corporation (LIXIL Group) (TOKYO:5938), a global leader in the housing and building industry, today announced that it has decided to sell 100% of the shares of Permasteelisa S.p.A (Permasteelisa) held by its major subsidiary LIXIL Corporation to Grandland Holdings Group Limited (Grandland), a leading Chinese architectural design and construction company. The transaction is subject to customary closing conditions and regulatory approvals, including in China, the United States and Russia. Under the terms of the agreement, the base sale price for Permasteelisa is EURO 467 million. As a result of this transaction and the deconsolidation of Permasteelisa from LIXIL Group, LIXIL Group’s revenue for the full fiscal year ending March 2018 is expected to decrease by approximately 170.0 billion yen from the amount announced on May 8, 2017 (by approximately 9.2% of the previously fore

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom